Macrophage Derived Chemokine (MDC) as an Anti-viral Agent for the Treatment and Prevention of Lentivirus Infections

Details for Australian Patent Application No. 2003204403 (hide)

Owner bioMerieux, Inc. University of Maryland Biotechnology Institute

Inventors Markham, Phillip D; Paal, Ranajit; Devico, Anthony L; Gallo, Robert C; Garzino-Demo, Alfredo

Agent Spruson & Ferguson

Pub. Number AU-A-2003204403

Parent 95704

Filing date 28 May 2003

Wipo publication date 26 June 2003

International Classifications

C07K 014/52 Peptides having more than 20 amino acids

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

19 June 2003 Complete Application Filed

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2003204403

15 March 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003204404-Real time radiation treatment planning system

2003204402-Set of Elements for Assembling Structures